Comera Life Sciences Holdings, Inc.

New Filing

CIK: 0001907685·Biotechnology·DELAWARE·Filed: Jan 8, 2024

Total Offering

$1,500,000

Amount Sold

$1,500,000

Investors

12

First Sale

Dec 29, 2023

Offering Details

Type: Debt, Option to Acquire
Exemptions: Rule 506(b)

Related Persons

Name	Role
Jeffrey S. Hackman	Executive Officer, Director
Michael Gerard Campbell	Executive Officer
Robert Patrick Mahoney	Executive Officer
James Sherblom	Director
Dorothy J. Clarke	Director
Edward Aloysius Sullivan Jr.	Director
Sirshendu Roopom Banerjee	Director
Kirsten Flowers	Director
William A. Wexler	Director

Company

Comera Life Sciences Holdings, Inc.

12 GILL STREET

WOBURN, MA, 01801

(617)871-2101

SEC Filing

0001907685-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.